BVS
BVS
NASDAQ · Health Care

Bioventus Inc - A

$9.78
+0.00 (+0.00%)
As of Jun 29, 10:09 PM ET ·
Financial Highlights (FY 2026)
Revenue
773.20M
Net Income
30.94M
Gross Margin
68.3%
Profit Margin
4.0%
Rev Growth
+3.5%
D/E Ratio
1.65
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 68.3% 68.3% 45.6% 45.6%
Operating Margin 9.4% 8.5% 15.0% 14.8%
Profit Margin 4.0% 3.8% 14.9% 11.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 773.20M 746.90M 241.82M 197.18M
Gross Profit 528.32M 510.36M 110.34M 89.97M
Operating Income 72.99M 63.46M 36.38M 29.11M
Net Income 30.94M 26.90M 36.10M 22.67M
Gross Margin 68.3% 68.3% 45.6% 45.6%
Operating Margin 9.4% 8.5% 15.0% 14.8%
Profit Margin 4.0% 3.8% 14.9% 11.5%
Rev Growth +3.5% +3.5% -4.8% -2.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 254.28M 254.28M 254.88M 304.50M
Total Equity 154.20M 154.20M 321.56M 308.93M
D/E Ratio 1.65 1.65 0.79 0.99
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 80.82M 74.16M 52.99M 46.00M
Free Cash Flow 25.01M 12.86M